The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain
Abstract
APPsw transgenic mice bearing the "Swedish" amyloid precursor protein (APP) mutation and JNPL3 transgenic mice bearing the P301L (Tau) mutation were compared to control non-transgenic (NT) mice in an extensive behavioral test battery administered between 5 and 8.5 months of age. APP mice were impaired in a variety of cognitive-based tasks prior to overt Abeta plaque development, making involvement of mutant APP overexpression and/or oligomeric Abeta assemblies most likely. Although Tau mice, as a group, were not impaired in any single behavioral measure, a collective assessment of behavioral measures through discriminant function analysis showed that Tau mice were impaired in overall behavioral (cognitive) performance. Moreover, correlation analyses involving Tau mice alone revealed linkage between poorer cognitive performance in all three water maze tasks and the number of neurofibrillary tangle (NFT)-containing neurons in neocortex and hippocampus. These findings indicate that: (1) APP mice show early and extensive cognitive impairment before evident Abeta deposition, and (2) the process or product of NFT formation in Tau mice is sufficient to deleteriously impact cognitive performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These spatial working memory deficits are generally accepted to be present across the rest of the life span for this model (Hsiao et al., 1996; Westerman et al., 2002; Arendash et al., 2004).”
From Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models (2014) · cites this paper as Arendash et al., 2004
In the citing paper
“In the Tg2576 mouse (Hsiao et al., 1996), the first presentation of cognitive deficits is seen at 5 months of age in spatial working memory (Arendash et al., 2004).”
From Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models (2014) · cites this paper as Arendash et al., 2004
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Self-citationAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506
Self-citationHolcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Self-citationLewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Self-citationIrwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09340.2002 · Cited by 763
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 731
Research works printed but not linked: 2
- Arendash, 2002, Early immunization with human β-amyloid protects against both short- and long-term cognitive impairment in APP+PS1 transgenic mice, Abstr.-Soc. Neurosci., 28, 227.4
- Nilsson, 2002, Cognitive impairment depends on ApoE and ACT-catalyzed amyloid formation in a mouse model of Alzheimer's disease, Abstr.-Soc. Neurosci., 28, 18.11
Cited by
Sorted by citations
Items 101–128 of 128
Chockanathan, U., & Padmanabhan, K. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012085 · Cited by 2
Bjugstad, K. B., Flitter, W. D., & Arendash, G. W. (2004) · Journal of Neuro-AIDS · doi:10.1300/j128v02n04_02 · Cited by 2
Self-citationAlzheimer model 5xfad mice and applications to dementia
Ayabe, T., & Ano, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00052-9 · Cited by 2
Jiang, Y., Tetlow, A. M., Lin, Y., Ji, C., Ader, J., Laborc, K. F., Mar, A. C., Pan, R., Kong, X., Congdon, E. E., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aea4205 · Cited by 2
Place cell physiology in a transgenic mouse model of Alzheimer's disease
Yi, M. (2009) · Cited by 1
Determining Attention Deficits In Mouse Models Of Alzheimer’s Disease Using Touchscreen Systems
Masood, T. S. (2015) · Scholarship@Western (Western University) · Cited by 1
Effects of curcuminoids on cognitive deficits in young audiovisually overstimulated mice
Tariq, A., Javed, S., Farhat, S. M., & Ahmed, T. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100565 · Cited by 2
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Leighty, R. E. (2009) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Self-citationEffec ts of hyperoxia in alzheimers transgenic mice
Cox, A. (2005) · Digital Commons - University of South Florida (University of South Florida)
Cracchiolo, J. R. (2005) · Digital Commons - University of South Florida (University of South Florida)
Self-citationFlavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology
Rezai-Zadeh, K. P. (2008) · Digital Commons - University of South Florida (University of South Florida)
Effects of long-term administration of caffeine in a mouse model for Alzheimer's disease
Schleif, W. S. (2005) · Digital Commons - University of South Florida (University of South Florida)
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Self-citationKorenova, M., & Stožická, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9378-2
Abnormalities of Amyloid Precursor Protein in the Etiology of Alzheimer’s disease
Waly, M. I. (2015) · Canadian Journal of Clinical Nutrition · doi:10.14206/canad.j.clin.nutr.2015.01.01
ENRIQUECIMIENTO AMBIENTAL EN RATONES 3xTgAD
Alzheimer, M. D. (2011)
In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
Richard, B. C. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5098
Creighton, S. D. (2019) · The Atrium (University of Guelph)
Alzheimer's Disease In Vivo Models: A Traditional Review
TÜTÜNCÜ, S., Yalçın, H. T., ÖZYURT, A. B., Yirün, A., Baydar, T., & Erkekoğlu, P. (2023) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2022-90431
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Role and relation of cell death in Alzheimer’s disease
Hoang, D. A., Le, D. A., Do, T. M. H., & Than, V. T. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2025.06.024
Dietrich, K. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4863
Additional file 1 of Synaptic tau: A pathological or physiological phenomenon?
Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Figshare · doi:10.6084/m9.figshare.16599510
Investigating the role of EFhd2 protein in modulating tau pathology in a tauopathy mouse model
Soliman, A. S., Umstead, A., & Vega, I. E. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1833887
Metadata
- Authors
- Arendash, G. W., Lewis, J., Leighty, R. E., McGowan, E., Cracchiolo, J. R., Hutton, M., & Garcia, M. F.
- Affiliations
- University of South Florida (US)
- Mayo Clinic (US)
- Corresponding author
- Arendash, Gary W
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 1012
- Issue
- 1-2
- Pages
- 29-41
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2111050644
- Cited by
- 127
- References
- 32
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 6 · 2012: 9
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, P301L tau mutation, cognitive impairment, amyloid precursor protein, amyloid-beta oligomers, neurofibrillary tangles, water maze, hippocampus, neocortex, behavioral phenotypes, discriminant function analysis
- MeSH terms
- Alzheimer Disease, Animals, Behavior, Animal, Cognition Disorders, Female, Mice, Inbred C57BL, Mice, Transgenic, Models, Neurological, Reaction Time, Prosencephalon, Amyloid beta-Protein Precursor, tau Proteins, Point Mutation, Maze Learning, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
